Scilex Holding Co — Director's Dealing 2024

Oct 31, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Scilex Holding Co (SCLX)
CIK: 0001820190
Period of Report: 2024-10-31

Reporting Person: Ji Henry (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-31	Common Stock	P	8888	$0.9396	Acquired	320161	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60070	Indirect
Common Stock	2749	Indirect
Common Stock	292264	Indirect
Common Stock	5640	Indirect

Footnotes

F1: Open market purchase by the reporting person of 8,888 shares of common stock, par value $0.0001 per share (the "Common Stock").

F2: On December 30, 2022, the Board of Directors of Sorrento Therapeutics, Inc. ("Sorrento") declared a stock dividend (the "Dividend") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of Common Stock for each one share of common stock, par value $0.0001 per share, of Sorrento ("Sorrento Common Stock"). The Reporting Person wrote a put option in Sorrento Common Stock on August 26, 2022 (the "Put Option"), which was adjusted as a result of the Stock Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,749 shares of Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Common Stock.

F3: The Put Option settled on March 17, 2023 and resulted in the Reporting Person becoming entitled to receive 2,749 shares of Common Stock at a price of $8.6002 per share of Common Stock, upon the expiration of the lock-up on such shares which is currently set to expire on January 31, 2025.

F4: Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.